Join to view full profile
39901 Traditions DrNorthville, MI 48168
Phone+1 248-305-4400
Fax+1 248-305-4401
Dr. Akin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1996 - 1999
University of Louisville School of MedicineResidency, Internal Medicine, 1993 - 1996
Istanbul University FomClass of 1988
Certifications & Licensure
MI State Medical License 2003 - 2027
MA State Medical License 2009 - 2017
MD State Medical License 1996 - 2004
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2016
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2016
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2016
Clinical Trials
Publications & Presentations
PubMed
- Mast cell activation syndrome: Global perspectives from a World Allergy Organization survey on knowledge, diagnosis, and access to care.Pedro Giavina-Bianchi, Mara Giavina-Bianchi, Mário Morais-Almeida, Iván Álvarez-Twose, Jonathan A Bernstein
The World Allergy Organization Journal. 2026-10-01 - Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.Cem Akin, Vito Sabato, Jason Gotlib, Jens Panse, Iván Álvarez-Twose
The Journal of Allergy and Clinical Immunology. 2026-08-01 - Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM).James C Marcus, Cem Akin, Jenna Zhang, Rachael Easton, Michelle Lim-Watson
Quality of Life Research. 2026-06-19
Lectures
- Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inade...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Other
- Original Article the Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and BeyondCem Akin, MD, ScienceDirect
https://www.doximity.com/articles/b432751a-ab97-4bd1-babc-759b194081d6
UpToDate, Wolters Kluwer Health - 2013-02-08 - Original Article the Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and BeyondCem Akin, MD, ScienceDirect
https://www.doximity.com/articles/b432751a-ab97-4bd1-babc-759b194081d6
UpToDate, Wolters Kluwer Health - 2012-05-11 - Original Article the Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and BeyondCem Akin, MD, ScienceDirect
https://www.doximity.com/articles/b432751a-ab97-4bd1-babc-759b194081d6
UpToDate, Wolters Kluwer Health - 2012-11-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: